Nongenomic effects of 17β-estradiol-diversity of membrane binding sites

被引:32
作者
Sak, K [1 ]
Everaus, H [1 ]
机构
[1] Univ Tartu, Hematol Oncol Clin, EE-51003 Tartu, Estonia
关键词
17; beta-estradiol; rapid nongenornic responses; membrane binding sites;
D O I
10.1016/j.jsbmb.2004.01.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The classical model of the action of 17beta-estradiol comprises binding of this gonadal steroid hormone to nuclear estrogen receptors leading to the modulation of gene transcription and protein synthesis. However, in the last few years several evidences about the rapid nongenomic action of 17beta-estradiol via the stimulation of putative receptors located in the cell membrane have also been reported. These nongenomic responses occur within a few minutes and are insensitive to the inhibitors of transcription and translation; however, no such membrane receptors have been cloned so far. In this review article, we present a survey showing that such membrane binding sites of 17beta-estradiol have rather different ligand specificity properties than that of classical genomic estrogen receptors concerning the potential activity of different estrogens and other steroid hormones, supporting the conception of structurally distinct receptors for genomic and nongenomic pathways. The fact that rapid responses to 17beta-estradiol could be induced by a wide concentration range from some piconiolar to high micromolar doses points to the diversity of these nongenomic membrane binding sites as well as the complexity of their functioning. (C) 2004 Published by Elsevier Ltd.
引用
收藏
页码:323 / 335
页数:13
相关论文
共 51 条
[1]   ESTROGEN ACTION VIA THE CAMP SIGNALING PATHWAY - STIMULATION OF ADENYLATE-CYCLASE AND CAMP-REGULATED GENE-TRANSCRIPTION [J].
ARONICA, SM ;
KRAUS, WL ;
KATZENELLENBOGEN, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8517-8521
[2]   EVIDENCE FOR A SPECIFIC ESTRADIOL BINDING-SITE ON RAT PITUITARY MEMBRANES [J].
BRESSION, D ;
MICHARD, M ;
LEDAFNIET, M ;
PAGESY, P ;
PEILLON, F .
ENDOCRINOLOGY, 1986, 119 (03) :1048-1051
[3]   Estrogen-specific target site identified by progesterone-11 alpha-hemisuccinate-(2-[I-125]-iodohistamine) in mouse brain membranes [J].
Bukusoglu, C ;
Krieger, NR .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1996, 58 (01) :89-94
[4]   The role of the I-sK protein in the specific pharmacological properties of the I-Ks channel complex [J].
Busch, AE ;
Busch, GL ;
Ford, E ;
Suessbrich, H ;
Lang, HJ ;
Greger, R ;
Kunzelmann, K ;
Attali, B ;
Stuhmer, W .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (02) :187-189
[5]   Non-genomic inhibition of human P2X7 purinoceptor by 17β-oestradiol [J].
Cario-Toumaniantz, C ;
Loirand, G ;
Ferrier, L ;
Pacaud, P .
JOURNAL OF PHYSIOLOGY-LONDON, 1998, 508 (03) :659-666
[6]   Nongenomic steroidal modulation of high-affinity serotonin transport [J].
Chang, AS ;
Chang, SM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1999, 1417 (01) :157-166
[7]   Comparison of estrogen concentrations, estrone sulfatase and aromatase activities in normal, and in cancerous, human breast tissues [J].
Chetrite, GS ;
Cortes-Prieto, J ;
Philippe, JC ;
Wright, F ;
Pasqualini, JR .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2000, 72 (1-2) :23-27
[8]  
Clarke R, 2001, PHARMACOL REV, V53, P25
[9]   Inhibition of striatal dopamine transporter activity by 17β-estradiol [J].
Disshon, KA ;
Boja, JW ;
Dluzen, DE .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 345 (02) :207-211
[10]  
Falkenstein E, 2000, PHARMACOL REV, V52, P513